Advanced glycation end-products (AGEs) constitute a non-homogenous, chemically diverse
group of compounds formed either exogeneously or endogeneously on the course of …

A large body of evidence has emerged in the past decade supporting a role for the gut
microbiome in the regulation of blood pressure. The field has moved from association to …

An expanding body of research indicates a correlation between the gut microbiota and
various diseases. Metabolites produced by the gut microbiota act as mediators between the …

Trimethylamine N-oxide (TMAO) is a metabolite produced by the gut microbiota and has
been mainly associated with an increased incidence of cardiovascular diseases (CVDs) in …

The human gut harbors microbial ecology that is in a symbiotic relationship with its host and
has a vital function in keeping host homeostasis. Inimical alterations in the composition of …

Recent preclinical and observational cohort studies have implicated imbalances in gut
microbiota composition as a contributor to atrial fibrillation (AF). The gut microbiota is a …

The human gut microbiota environment is constantly changing and some specific changes
influence the host's metabolic, immune, and neuroendocrine functions. Emerging evidence …

The aim of the present review was to summarize the potential interactive effects between the
gut microbiota and advanced glycation end‑product (AGE) accumulation and toxicity in the …

Recently, trimethylamine N-oxide (TMAO) has been considered a risk factor for
cardiovascular disease and has a proatherogenic effect. Many studies have found that …

Cellular senescence is a biological aging hallmark that plays a key role in the development
of neurodegenerative diseases. Clinical trials are currently underway to evaluate the …